Developmental Research Program

NIH RePORTER · NIH · P50 · $85,920 · view on reporter.nih.gov ↗

Abstract

Project Summary The objective of the Glioma SPORE Developmental Research Program (DRP) is to identify innovative pilot research projects in glioma that have translational potential. The DRP utilizes a solicitation and review process to select meritorious pilot projects for funding. The solicitation process capitalizes on an established, extensive Dana-Farber/Harvard Cancer Center (DF/HCC) communications infrastructure to widely disseminate an annual Request for Proposals (RFP). The review process utilizes an experienced panel of DF/HCC glioma scientists. The DRP provides limited-duration funding for innovative projects that have ultimate translational potential and could synergize with existing SPORE projects and cores. DF/HCC institutions match DRP funding from this SPORE to expand the pool of DRP awardees. The DRP applications are judged for their potential as pilot or collaborative studies that will generate feasibility data and for potential to emerge as full projects in future years of the SPORE program. The DRP employs a monitoring process to measure progress and outcomes of DRP projects with clearly established metrics and oversight by the DRP Awards Committee. DRP awardees are required to present progress reports at the annual SPORE retreat attended by all SPORE Internal and External Advisory Boards.

Key facts

NIH application ID
10935607
Project number
2P50CA165962-11
Recipient
BRIGHAM AND WOMEN'S HOSPITAL
Principal Investigator
Tracy T Batchelor
Activity code
P50
Funding institute
NIH
Fiscal year
2024
Award amount
$85,920
Award type
2
Project period
2013-09-19 → 2029-08-31